AIM
VBIV

Axiom Investment Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Axiom Investment Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3
Closed – – 449
2022
Q3 		$0 Buy
+3
New +$81 ﹤0.01% 471

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Axiom Investment Management's VBIV Position: Q4 2022 in Review

Axiom Investment Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2022, closing a stake of 3 shares.

Axiom Investment Management first reported a position in VBIV in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 112 funds tracked by Wall St. Rank hold VBIV as of Q4 2022.

  • Axiom Investment Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2022 after selling out during the quarter.
  • Axiom Investment Management sold 3 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2022.
  • Axiom Investment Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2022 and held it in 1 quarter.
  • Axiom Investment Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $0 in Q3 2022.
  • 112 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2022.

Based on Axiom Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.